Liposomal bupivacaine formulary restrictions

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

3 posts / 0 new
Log in or register to post comments
Last post
Mon, 08/01/2022 - 13:49
#1
Jacyntha Sterling
Jacyntha Sterling's picture
Offline
Last seen: 1 year 10 months ago
Joined: 12/10/2019 - 14:49
Liposomal bupivacaine formulary restrictions

Good afternoon!

What is your organization's formulary status for liposomal bupivacaine injection? If it is on formulary, how is it restricted?

Managing utilization safely is challenging, given the logistics of utilization in a surgical world and acute-on-chronic rolling shortages of unencapsulated local anesthetic alternatives.

The following review provides a summary of trials for acute postsurgical pain:
Ilfeld BM, Eisenach JC, Gabriel RA. Clinical Effectiveness of Liposomal Bupivacaine Administered by Infiltration or Peripheral Nerve Block to Treat Postoperative Pain. Anesthesiology. 2021 Feb 1;134(2):283-344. doi: 10.1097/ALN.0000000000003630. PMID: 33372949.

Thanks very much!

Tags: 

Top